Mendelian Randomization and Transcriptomic Analysis Identify HE4 as a Potential Biomarker for Chronic Obstructive Pulmonary Disease
Clinical Laboratory · 2026 · 72 (06/2026)
DOI: 10.7754/clin.lab.2025.250536 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Laboratory, 2026. Verfasst von Mei-Xue Li und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, WAP Four-Disulfide Core Domain Protein 2, Gene Expression Profiling, Mendelian Randomization Analysis.
Themen: COPD
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Li, M. X., Zeng, Z. F., & Cao, Z. W. (2026). Mendelian Randomization and Transcriptomic Analysis Identify HE4 as a Potential Biomarker for Chronic Obstructive Pulmonary Disease. Clinical Laboratory, 72(06/2026). https://doi.org/10.7754/clin.lab.2025.250536
Vancouver
Li MX, Zeng ZF, Cao ZW. Mendelian Randomization and Transcriptomic Analysis Identify HE4 as a Potential Biomarker for Chronic Obstructive Pulmonary Disease. Clinical Laboratory. 2026;72(06/2026). doi:10.7754/clin.lab.2025.250536
BibTeX
@article{Li2026,
author = {Li, Mei-Xue and Zeng, Zhang-Fang and Cao, Zhao-Wen},
title = {Mendelian Randomization and Transcriptomic Analysis Identify HE4 as a Potential Biomarker for Chronic Obstructive Pulmonary Disease},
journal = {Clinical Laboratory},
year = {2026},
volume = {72},
number = {06/2026},
doi = {10.7754/clin.lab.2025.250536}
}
EUVIMED